ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Andere talen Zylox-Tonbridge Medical Technology Co., Ltd.

Aandelen

2190

CNE100004JD2

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:20 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,34 ^HKD	+0,98%		+9,07%	-16,88%

22/03	Zylox-Tonbridge krimpt verlies met 31% in boekjaar 2023	MT
21/03	Zylox-Tonbridge Medical Technology Co, Ltd. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	22/03
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket	07/03
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker	07/03
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd	07/03
Avinger, Inc. announced that it expects to receive $15 million in funding from Zylox-Tonbridge Medical Technology Co., Ltd.	04/03
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE	21/02
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7%	22/01
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System	22/01
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System	29/12
Zylox Tonbridge Secures Chinese Marketing Approval for Arterial Embolization Device	29/12
Zylox-Tonbridge Completes Patient Enrolment for Post-Marketing Clinical Trial of Stent System in EU	21/12
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany	20/12
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval	11/12
China Grants Marketing Approval to Zylox-Tonbridge's Balloon Catheter	11/12
China Gives Marketing Approval for Zylox-Tonbridge's Blood Vessel Distal Support Catheter	06/12
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Change of Address of Registered Office	07/11
Zylox-Tonbridge Medical Technology Co., Ltd. commences an Equity Buyback Plan for 32,461,974 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023.	07/11
Zylox-Tonbridge Trustee Buys About 1.1 Million Shares Under Share Award, Trust Scheme; Shares Jump 5%	06/11
Zylox-Tonbridge Medical Buys Back 1.1 Million Shares	13-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zylox-Tonbridge Medical Technology Co., Ltd.

Aandelen

2190

CNE100004JD2

Andere talen

Filters